MiR-93-5p Promotes Cell Proliferation through Down-Regulating PPARGC1A in Hepatocellular Carcinoma Cells by Bioinformatics Analysis and Experimental Verification

Peroxisome proliferator-activated receptor gamma coactivator-1 alpha (PPARGC1A, formerly known as PGC-1a) is a transcriptional coactivator and metabolic regulator. Previous studies are mainly focused on the association between PPARGC1A and hepatoma. However, the regulatory mechanism remains unknown. A microRNA associated with cancer (oncomiR), miR-93-5p, has recently been found to play an essential role in tumorigenesis and progression of various carcinomas, including liver cancer. Therefore, this paper aims to explore the regulatory mechanism underlying these two proteins in hepatoma cells. Firstly, an integrative analysis was performed with miRNA–mRNA modules on microarray and The Cancer Genome Atlas (TCGA) data and obtained the core regulatory network and miR-93-5p/PPARGC1A pair. Then, a series of experiments were conducted in hepatoma cells with the results including miR-93-5p upregulated and promoted cell proliferation. Thirdly, the inverse correlation between miR-93-5p and PPARGC1A expression was validated. Finally, we inferred that miR-93-5p plays an essential role in inhibiting PPARGC1A expression by directly targeting the 3′-untranslated region (UTR) of its mRNA. In conclusion, these results suggested that miR-93-5p overexpression contributes to hepatoma development by inhibiting PPARGC1A. It is anticipated to be a promising therapeutic strategy for patients with liver cancer in the future.

[1]  Quan Zou,et al.  Computational Identification of MicroRNAs and Their Targets in Perennial Ryegrass (Lolium perenne) , 2014, Applied Biochemistry and Biotechnology.

[2]  Yong Huang,et al.  In Silico Prediction of Gamma-Aminobutyric Acid Type-A Receptors Using Novel Machine-Learning-Based SVM and GBDT Approaches , 2016, BioMed research international.

[3]  Quan Zou,et al.  Briefing in family characteristics of microRNAs and their applications in cancer research. , 2014, Biochimica et biophysica acta.

[4]  Q. Zou,et al.  Prediction and Identification of Krüppel-Like Transcription Factors by Machine Learning Method. , 2017, Combinatorial chemistry & high throughput screening.

[5]  J. Minna,et al.  miR-93-directed down-regulation of DAB2 defines a novel oncogenic pathway in lung cancer , 2013, Oncogene.

[6]  Xiangxiang Zeng,et al.  Integrative approaches for predicting microRNA function and prioritizing disease-related microRNA using biological interaction networks , 2016, Briefings Bioinform..

[7]  P. Metrakos,et al.  (18)F-Fluorodeoxyglucose positron-emission tomography could have a prognostic role in patients with advanced hepatocellular carcinoma. , 2014, Current oncology.

[8]  Meili Fu,et al.  Activation of mPTP-dependent mitochondrial apoptosis pathway by a novel pan HDAC inhibitor resminostat in hepatocellular carcinoma cells. , 2016, Biochemical and biophysical research communications.

[9]  Quan Zou,et al.  Identification of DEP domain-containing proteins by a machine learning method and experimental analysis of their expression in human HCC tissues , 2016, Scientific Reports.

[10]  Junji Furuse,et al.  The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. , 2010, The oncologist.

[11]  Z. Derdák,et al.  Obesity-associated mechanisms of hepatocarcinogenesis. , 2014, Metabolism: clinical and experimental.

[12]  C. Croce,et al.  MicroRNAs in Cancer. , 2009, Annual review of medicine.

[13]  P. Puigserver,et al.  Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. , 2003, Endocrine reviews.

[14]  Thomas Thurnherr,et al.  Differentially Expressed miRNAs in Hepatocellular Carcinoma Target Genes in the Genetic Information Processing and Metabolism Pathways , 2016, Scientific Reports.

[15]  C. Croce,et al.  SnapShot: MicroRNAs in Cancer , 2009, Cell.

[16]  Limin Jiang,et al.  BP Neural Network Could Help Improve Pre-miRNA Identification in Various Species , 2016, BioMed research international.

[17]  Q. Zou,et al.  Similarity computation strategies in the microRNA-disease network: a survey. , 2015, Briefings in functional genomics.

[18]  Patrick J. Paddison,et al.  Causal Mechanistic Regulatory Network for Glioblastoma Deciphered Using Systems Genetics Network Analysis. , 2016, Cell systems.

[19]  Q. Zou,et al.  Construction and Identification of the RNAi Recombinant Lentiviral Vector Targeting Human DEPDC7 Gene , 2016, Interdisciplinary Sciences: Computational Life Sciences.

[20]  R. Kim,et al.  Role of Systemic Therapy and Future Directions for Hepatocellular Carcinoma , 2017, Cancer control : journal of the Moffitt Cancer Center.

[21]  Tingming Liang,et al.  miR-isomiRExp: a web-server for the analysis of expression of miRNA at the miRNA/isomiR levels , 2016, Scientific Reports.

[22]  W. Guo,et al.  MiR‐93‐5p inhibits the EMT of breast cancer cells via targeting MKL‐1 and STAT3 , 2017, Experimental cell research.

[23]  C. Lindskog.  The Human Protein Atlas – an important resource for basic and clinical research , 2016, Expert review of proteomics.

[24]  Libing Song,et al.  miR-93 Promotes Cell Proliferation in Gliomas through Activation of PI 3 K / Akt Signaling Pathway , 2015 .

[25]  Quan Zou,et al.  Identification of MicroRNA Genes and their mRNA Targets in Festuca arundinacea , 2014, Applied Biochemistry and Biotechnology.

[26]  G. Reynolds,et al.  Development of hepatocellular carcinoma in a murine model of nonalcoholic steatohepatitis induced by use of a high-fat/fructose diet and sedentary lifestyle. , 2014, The American journal of pathology.

[27]  Xiangxiang Zeng,et al.  Inferring MicroRNA-Disease Associations by Random Walk on a Heterogeneous Network with Multiple Data Sources , 2017, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[28]  M. Tan,et al.  The Warburg effect in tumor progression: mitochondrial oxidative metabolism as an anti-metastasis mechanism. , 2015, Cancer letters.

[29]  Lingling Zhu,et al.  MiR-93-5p promotes gastric cancer-cell progression via inactivation of the Hippo signaling pathway. , 2018, Gene.

[30]  Ting Wang,et al.  Exploring long-range genome interactions using the WashU Epigenome Browser , 2013, Nature Methods.

[31]  K. Zen,et al.  Peroxisome proliferator-activated receptor gamma coactivator-1 alpha acts as a tumor suppressor in hepatocellular carcinoma , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[32]  T. Takayama.  Surgical treatment for hepatocellular carcinoma. , 2011, Japanese journal of clinical oncology.

[33]  Quan Zou,et al.  Which statistical significance test best detects oncomiRNAs in cancer tissues? An exploratory analysis , 2016, Oncotarget.

[34]  Michael Snyder,et al.  A highly integrated and complex PPARGC1A transcription factor binding network in HepG2 cells , 2012, Genome research.

[35]  Ming-Hua Zheng,et al.  Hepatocellular carcinoma associated microRNA expression signature: integrated bioinformatics analysis, experimental validation and clinical significance , 2015, Oncotarget.

[36]  S. Ohta,et al.  Molecular hydrogen stimulates the gene expression of transcriptional coactivator PGC-1α to enhance fatty acid metabolism , 2016, npj Aging and Mechanisms of Disease.

[37]  E. Riboli,et al.  Prospective association of liver function biomarkers with development of hepatobiliary cancers. , 2016, Cancer epidemiology.

[38]  Jinhua Wang,et al.  MicroRNA-93 activates c-Met/PI3K/Akt pathway activity in hepatocellular carcinoma by directly inhibiting PTEN and CDKN1A , 2014, Oncotarget.

[39]  Jiandie D. Lin,et al.  Defects in Adaptive Energy Metabolism with CNS-Linked Hyperactivity in PGC-1α Null Mice , 2004, Cell.

[40]  Huanming Yang,et al.  The Symbiodinium kawagutii genome illuminates dinoflagellate gene expression and coral symbiosis , 2015, Science.

[41]  Q. Guo,et al.  Comprehensive analysis of lncRNA-mRNA co-expression patterns identifies immune-associated lncRNA biomarkers in ovarian cancer malignant progression , 2015, Scientific Reports.

[42]  Q. Zou,et al.  Prediction of MicroRNA-Disease Associations Based on Social Network Analysis Methods , 2015, BioMed research international.

[43]  F. Marincola,et al.  TGFβR2 is a major target of miR-93 in nasopharyngeal carcinoma aggressiveness , 2014, Molecular Cancer.

[44]  Tingming Liang,et al.  A Comprehensive Analysis of miRNA/isomiR Expression with Gender Difference , 2016, PloS one.

[45]  Lingling Hu,et al.  miRClassify: An advanced web server for miRNA family classification and annotation , 2014, Comput. Biol. Medicine.